Australia's most trusted
source of pharma news
Friday, 29 August 2025
Posted 26 August 2025 AM
Kenvue has officially entered the lucrative vaping market, with the first TGA approved therapy to combat cravings and help Australians quit the habit.
The Johnson & Johnson consumer healthcare spin-off has secured an expanded indication for its nicotine-containing buccal spray NICORETTE QuickMist, which is available in freshmint and cool berry flavours at pharmacies and major supermarkets across Australia.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.